A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Clinical trial NCT07123038 · RECRUITING

Trial details

NCT number: NCT07123038
Sponsor: Sonoma Biotherapeutics, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Rheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)

Start date: 2025-07-22
Primary completion: 2040-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.